Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL900705 | 0.77 | — | — | |
| SCHEMBL28854334 | 0.74 | — | — | |
| SCHEMBL11054901 | 0.74 | — | — | |
| SCHEMBL785343 | 0.74 | — | — | |
| SCHEMBL9073485 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL11056768 | 0.72 | — | — | |
| SCHEMBL16571102 | 0.72 | OPRM1 (0.35) | — | |
| SCHEMBL28267105 | 0.72 | — | — | |
| SCHEMBL7165676 | 0.69 | — | — | |
| SCHEMBL25892699 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240317678-A1 | METHOD FOR PREPARING ISOCYANATE COMPOUND | Hanwha Solutions Corporation (KR) | 2024-09-26 | — | — | US | claimed |
| US-20240317679-A1 | METHOD FOR PREPARING ISOCYANATE COMPOUND | Hanwha Solutions Corporation (KR) | 2024-09-26 | — | — | US | claimed |
| US-20240067602-A1 | METHOD FOR PREPARING ISOCYANATE COMPOUND | Hanwha Solutions Corporation (KR) | 2024-02-29 | — | — | US | claimed |
| US-20240067601-A1 | METHOD FOR PREPARING ISOCYANATE COMPOUND | Hanwha Solutions Corporation (KR) | 2024-02-29 | — | — | US | claimed |
| WO-2022146088-A1 | ISOCYANATE COMPOUND PREPARATION METHOD | 한화솔루션 주식회사 | 2022-07-07 | — | — | WO | claimed |
| WO-2022146090-A1 | ISOCYANATE COMPOUND PREPARATION METHOD | 한화솔루션 주식회사 | 2022-07-07 | — | — | WO | claimed |
| WO-2022146091-A1 | METHOD FOR PREPARING ISOCYANATE COMPOUND | 한화솔루션 주식회사 | 2022-07-07 | — | — | WO | claimed |
| WO-2022146092-A1 | METHOD FOR PREPARING ISOCYANATE COMPOUND | 한화솔루션 주식회사 | 2022-07-07 | — | — | WO | claimed |
| US-12503427-B2 | Diamine composition, and method of preparing diisocyanate composition | SK pucore co., ltd (KR) | 2025-12-23 | — | — | US | disclosed |
| US-12146023-B2 | Method for manufacturing diisocyanate and optical lens | WOORI FINE CHEM CO., LTD. (KR) | 2024-11-19 | — | — | US | disclosed |
| US-20240317678-A1 | METHOD FOR PREPARING ISOCYANATE COMPOUND | Hanwha Solutions Corporation (KR) | 2024-09-26 | — | — | US | disclosed |
| US-20240317679-A1 | METHOD FOR PREPARING ISOCYANATE COMPOUND | Hanwha Solutions Corporation (KR) | 2024-09-26 | — | — | US | disclosed |
| US-12049437-B2 | Diisocyanate composition, preparation method thereof and optical material using same | SK PUCORE CO., LTD. (KR) | 2024-07-30 | — | — | US | disclosed |
| EP-3831806-B1 | DIISOCYANATE COMPOSITION FOR OPTICAL LENS AND PREPARATION METHOD THEREOF | SK PUCORE CO LTD (KR) | 2024-07-10 | — | — | EP | disclosed |
| WO-2015038493-A1 | SYNTHESIS OF NOVEL ASYMMETRIC BOW-TIE PAMAM DENDRIMER-BASED CONJUGATES FOR TUMOR-TARGETING DRUG DELIVERY | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2015-03-19 | — | — | WO | disclosed |
| WO-2013025287-A1 | DEGRADABLE DETERGENTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-02-21 | — | — | WO | disclosed |
| US-8183407-B2 | Process for production of isocyanate, isocyanate produced by the process, and use of the isocyanate | MITSUI CHEMICALS, INC. (JP) | 2012-05-22 | — | — | US | disclosed |
| US-20090124785-A1 | Process for production of isocyanate, isocyanate produced by the process, and use of the isocyanate | MITSUI CHEMICALS, INC. (JP) | 2009-05-14 | — | — | US | disclosed |
| EP-1908749-A1 | PROCESS FOR PRODUCTION OF ISOCYANATE, ISOCYANATE PRODUCED BY THE PROCESS, AND USE OF THE ISOCYANATE | Mitsui Chemicals, Inc. (JP) | 2008-04-09 | — | — | EP | disclosed |
| US-4957989-A | ANTIFOULING AGENT FOR SHIP BOTTOMS, NONTOXIC | TOSHIBA SILICONE CO., LTD. (JP) | 1990-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12049437-B2 | Diisocyanate composition, preparation method thereof and optical material using same | INCENP, IK, ALKBH5 | LAP3 4487/4885 |
| US-12146023-B2 | Method for manufacturing diisocyanate and optical lens | SMO, CRYAA, INCENP | LAP3 1605/4885 |
| US-12503427-B2 | Diamine composition, and method of preparing diisocyanate composition | INCENP, ALKBH5, TET1 | LAP3 2756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.